Library / Laws / 116th Congress / House Bills / H.R. 938

H.R. 938

To amend the Federal Food, Drug, and Cosmetic Act, with respect to eligibility for approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval, and for other purposes.

House · 2 versions on the shelf